Immune Design Corp (IMDZ)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

1616 EASTLAKE AVENUE E. SEATTLE, WA 98102

Immune Design Corp develops therapeutic vaccines. The Company creates synthetic compounds to boost the effectiveness of vaccines and technology designed to trigger a specific immune defense against viral and bacterial pathogens.

Data as of 2019-03-28 05:53:51 -0400
Market Cap282.453 Million Shares Outstanding48.365 Million Avg 30-day Volume
P/E Ratio Dividend Yield0.0 EPS-1.15
Price/Sales128.84184 Debt to Equity EBITDA0
Price to Book Value3.08 Forward PE Enterprise Value
Total Cash0 Current Debt Gross Profit0
BETA3.46278 52-week High/Low5.85 / 1.1 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud
View SEC Filings from IMDZ instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding IMDZ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IMDZ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PAYA CARLOS V PRESIDENT AND CEO

  • Officer
  • Director
0 2019-04-02 0

RINGO WILLIAM R

  • Director
0 2019-04-02 0

BALTIMORE DAVID

  • Director
0 2019-04-02 0

PENHOET EDWARD

  • Director
0 2019-04-02 0

BRADY STEPHEN R EVP, STRATEGY & FINANCE

  • Officer
0 2019-04-02 0

BERGER FRANKLIN M

  • Director
0 2019-04-02 0

TER MEULEN JAN HENRIK CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-04-02 0

GOMBOTZ WAYNE CHIEF DEVELOPMENT OFFICER

  • Officer
0 2019-04-02 0

COLEMAN LEWIS W

  • Director
0 2019-04-02 0

KELLEY SUSAN L.

  • Director
0 2019-04-02 0

YURASOV SERGEY SR. VP, CLINIC. DEVEL. & CMO

  • Officer
0 2019-04-02 0

COLUMN GROUP L P

COLUMN GROUP GP, LP

COLUMN GROUP II, LP

COLUMN GROUP II GP, LP

PONOI CAPITAL, LP

PONOI MANAGEMENT, LLC

GOEDDEL DAVID V

KUTZKEY TIM

SVENNILSON PETER

  • 10% Owner
  • GENERAL PARTNER GENERAL PARTNER GENERAL PARTNERMANAGING PARTNERMANAGING PARTNERMANAGING PARTNER
0 2019-04-02 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
No longer subject to file 2018-12-04 0

GUTHART LEO

  • 10% Owner
5,664,739 2018-01-08 0

SVENNILSON PETER

  • Director
  • 10% Owner
0 2018-01-04 0

PONOI CAPITAL, LP

PONOI MANAGEMENT, LLC

KUTZKEY TIM

  • 10% Owner
2,681,000 2017-10-27 0

COLUMN GROUP L P

COLUMN GROUP GP, LP

COLUMN GROUP II, LP

COLUMN GROUP II GP, LP

PONOI CAPITAL, LP

PONOI MANAGEMENT, LLC

GOEDDEL DAVID V

KUTZKEY TIM

  • 10% Owner
6,642,942 2017-10-27 0

COLUMN GROUP L P

COLUMN GROUP GP, LP

COLUMN GROUP II, LP

COLUMN GROUP II GP, LP

GOEDDEL DAVID V

  • 10% Owner
3,961,942 2016-09-20 0

COLUMN GROUP II, LP

COLUMN GROUP II GP, LP

  • 10% Owner
800,000 2016-09-20 0

TOPSPIN FUND L.P.

LG MANAGEMENT, LLC

GUTHART LEO

  • 10% Owner
3,098,239 2016-09-20 0

ATWOOD BRIAN G

  • Director
0 2016-01-04 0

KENNEY RICHARD T CHIEF MEDICAL OFFICER

  • Officer
7,522 2016-01-04 0

PROQUEST INVESTMENTS IV, L.P.

PROQUEST ASSOCIATES IV LLC

MOORIN JAY

SCHREIBER ALAIN

  • 10% Owner
No longer subject to file 2015-05-12 0

RICKEY JAMES PAUL VP, FINANCE AND ADMINISTRATION

  • Officer
0 2015-01-07 0

VERSANT VENTURE CAPITAL III, L.P.

VERSANT SIDE FUND III, L.P.

  • 10% Owner
2,208,210 2014-07-29 0

ALTA PARTNERS VIII, L.P.

ALTA PARTNERS MANAGEMENT VIII, LLC

NOHRA GUY P

JANNEY DANIEL

CHAMPSI FARAH

  • 10% Owner
2,482,775 2014-07-29 0

COLUMN GROUP L P

COLUMN GROUP GP, LP

GOEDDEL DAVID V

  • 10% Owner
3,161,942 2014-07-29 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments